Comparing Treatment of Dry Eye With Intracanalicular Dexamethasone, Restasis, and/or Lotemax

Exclusion Criteria

• •Patients under the age of 18.
• •Pregnancy (must be ruled out in women of child-bearing age with pregnancy test)
• •Active infectious systemic disease
• •Active infectious ocular or extraocular disease
• •Altered nasolacrimal flow of either acquired, induced, or congenital origin
• •Hypersensitivity to dexamethasone
• •Patients who have been on topical immunomodulating agents in the previous 3 months to their baseline visit
• •Patient being treated with either topical, oral, or intravenous immunosuppressive agents, immunomodulating agents, or steroid (including NSAIDS)
• •Patients with severe disease that warrants critical attention, deemed unsafe for the study by the investigator